carboxyamido-triazole has been researched along with daunorubicin in 1 studies
Studies (carboxyamido-triazole) | Trials (carboxyamido-triazole) | Recent Studies (post-2010) (carboxyamido-triazole) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
---|---|---|---|---|---|
105 | 15 | 22 | 8,239 | 886 | 1,310 |
Protein | Taxonomy | carboxyamido-triazole (IC50) | daunorubicin (IC50) |
---|---|---|---|
72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wiedemann, P | 1 |
1 other study(ies) available for carboxyamido-triazole and daunorubicin
Article | Year |
---|---|
1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferation.
Topics: Calcium Channel Blockers; Cell Adhesion; Cell Movement; Cell Survival; Daunorubicin; Humans; Immunotoxins; Integrins; Multicenter Studies as Topic; Peptides, Cyclic; Pigment Epithelium of Eye; Retinal Neovascularization; Triazoles; Vitreoretinopathy, Proliferative | 1999 |